Evidence map›Paper›PMID 31159404›Full record

ArticleJournal of clinical medicine2019

Plasma microRNA Profiling Reveals Novel Biomarkers of Epicardial Adipose Tissue: A Multidetector Computed Tomography Study.

David de Gonzalo-Calvo, David Vilades, Pablo Martínez-Camblor, Àngela Vea, Andreu Ferrero-Gregori, Laura Nasarre, Olga Bornachea, Jesus Sanchez Vega, Rubén Leta, Núria Puig and 4 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Observational
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

David de Gonzalo-CalvoInstitute of Biomedical Research of Barcelona (IIBB) - Spanish National Research Council (CSIC), 08036 Barcelona, Spain. david.degonzalo@gmail.com.ORCID 0000-0003-2240-3532
David ViladesCardiac Imaging Unit, Cardiology Department, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain. DVilades@santpau.cat.
Pablo Martínez-CamblorGeisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA. pablo.martinez.camblor@dartmouth.edu.ORCID 0000-0001-7845-3905
Àngela VeaBiomedical Research Institute Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain. angelavea@gmail.com.
Andreu Ferrero-GregoriCIBERCV, Institute of Health Carlos III, 28029 Madrid, Spain. AFerrero@santpau.cat.
Laura NasarreBiomedical Research Institute Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain. lnasarre@santpau.cat.
Olga BornacheaInstitute of Biomedical Research of Barcelona (IIBB) - Spanish National Research Council (CSIC), 08036 Barcelona, Spain. olgabornachea79@gmail.com.
Jesus Sanchez VegaCardiac Imaging Unit, Cardiology Department, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain. JSanchezV@santpau.cat.
Rubén LetaCardiac Imaging Unit, Cardiology Department, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain. RLeta@santpau.cat.
Núria PuigCardiovascular Biochemistry, Biomedical Research Institute Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain. NPuigG@santpau.cat.
Sonia BenítezCardiovascular Biochemistry, Biomedical Research Institute Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain. SBenitez@santpau.cat.
Jose Luis Sanchez-QuesadaCardiovascular Biochemistry, Biomedical Research Institute Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain. JSanchezQ@santpau.cat.
Francesc CarrerasCIBERCV, Institute of Health Carlos III, 28029 Madrid, Spain. FCarreras@santpau.cat.
Vicenta Llorente-CortésInstitute of Biomedical Research of Barcelona (IIBB) - Spanish National Research Council (CSIC), 08036 Barcelona, Spain. cllorente@santpau.cat.

Funding

Fundació Marató TV3 Project 201521-10 and Project 201716Instituto de Salud Carlos III CIBER Cardiovascular (CB16/11/00403 to VL-C and DdG-C and CB16/11/00276 to AF-G) and CIBERDEM (CB07/08/0016 to JLS-Q)Instituto Salud Carlos III FIS PI14/01729 (to VL-C), FIS PI16/00471 (to JLS-Q) & FIS PI18/01584 (to VL-C)Ministerio de Economía y Competitividad IJCI-2016-29393
6 · The paper itself

Abstract

Epicardial adipose tissue (EAT) constitutes a novel parameter for cardiometabolic risk assessment and a target for therapy. Here, we evaluated for the first time the plasma microRNA (miRNA) profile as a source of biomarkers for epicardial fat volume (EFV). miRNAs were profiled in plasma samples from 180 patients whose EFV was quantified using multidetector computed tomography. In the screening study, 54 deregulated miRNAs were identified in patients with high EFV levels (highest tertile) compared with matched patients with low EFV levels (lowest tertile). After filtering, 12 miRNAs were selected for subsequent validation. In the validation study, miR-15b-3p, miR-22-3p, miR-148a-3p miR-148b-3p and miR-590-5p were directly associated with EFV, even after adjustment for confounding factors (

Indexed as

biomarkercardiometabolic diseaseepicardial adipose tissueepicardial fatepicardial fat volumemicroRNA

Identifiers

PMID31159404
PMCPMC6616954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.